首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors.
【24h】

The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors.

机译:5-HT(1A)受体激动剂8-OH-DPAT可阻止皮质NMDA受体的响应而释放前额叶谷氨酸和5-羟色胺。

获取原文
获取原文并翻译 | 示例
       

摘要

We studied the role of 5-HT(1A) receptors in controlling the release of glutamate (GLU) in the medial prefrontal cortex (mPFC) of conscious rats with the in vivo microdialysis technique. The effect of the 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin infused in the prefrontal cortex was examined under basal conditions and on the rise of extracellular GLU (+106%) induced by co-infusion of the competitive N-methyl-d-aspartate receptor antagonist 3-[(R)-2-carboxypiperazin-4yl]-propyl-1-phosphonic acid (CPP). 8-OH-DPAT (0.3 and 3 microm) had no effect on basal extracellular GLU, but the higher concentration completely abolished the rise of extracellular GLU induced by CPP. CPP also increased extracellular serotonin (5-HT) in the mPFC (+50%) and this effect was antagonized by 3 microm 8-OH-DPAT which, by itself, had no effect on basal 5-HT release. The effects of 8-OH-DPAT on extracellular GLU and 5-HT were reversed by the 5-HT(1A) receptor antagonist WAY100 635 (100 microm), indicating aselective involvement of 5-HT(1A) receptors. WAY100 635 had no effect by itself. These results show that the stimulation of cortical 5-HT(1A) receptors prevents the CPP-evoked rise of extracellular GLU and 5-HT and suggest that these effects may contribute to the ability of intracortical 8-OH-DPAT to counteract cognitive deficits caused by the blockade of NMDA receptors.
机译:我们通过体内微透析技术研究了5-HT(1A)受体在控制清醒大鼠内侧前额叶皮层(mPFC)中的谷氨酸(GLU)释放中的作用。在基础条件下检查了5-HT(1A)受体激动剂8-羟基-2-(二-正丙基氨基)四氢叶酸注入前额叶皮层中的作用,以及对5-HT(1A)受体激动剂诱导的细胞外GLU升高的影响(+ 106%)共注入竞争性N-甲基-d-天冬氨酸受体拮抗剂3-[((R)-2-羧基哌嗪-4基]-丙基-1-膦酸(CPP))。 8-OH-DPAT(0.3和3微米)对基础细胞外GLU没有影响,但较高的浓度完全消除了CPP诱导的细胞外GLU的上升。 CPP还增加了mPFC中的细胞外血清素(5-HT)(+ 50%),这种作用被3微米的8-OH-DPAT所拮抗,其本身对基础5-HT的释放没有影响。 5-HT(1A)受体拮抗剂WAY100 635(100 microm)逆转了8-OH-DPAT对细胞外GLU和5-HT的作用,表明5-HT(1A)受体的选择性参与。 WAY100 635本身没有作用。这些结果表明,刺激皮质5-HT(1A)受体可阻止CPP引起的细胞外GLU和5-HT的升高,并表明这些作用可能有助于皮质内8-OH-DPAT抵消引起的认知功能障碍的能力。通过NMDA受体的阻断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号